Litcius/Paper detail

The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways

Zhihong Liao, Hongqing Zhu, Yanyan Chen, Run-Li Chen, Li-Xiang Fu, Li Li, Huan Zhou, Jinling Zhou, Gang Liang

2020Journal of Ethnopharmacology67 citationsDOI

Topics & Concepts

AngiogenesisProtein kinase BPI3K/AKT/mTOR pathwayMAPK/ERK pathwayChorioallantoic membraneIn vivoCancer researchWestern blotChemistryBiologySignal transductionBiochemistryBiotechnologyGeneTea Polyphenols and EffectsTannin, Tannase and Anticancer ActivitiesFlavonoids in Medical Research
The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways | Litcius